Ryan J.O. Dowling
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Molecular Biology top 1%
- Metabolism, Diabetes, and Cancer
- PI3K/AKT/mTOR signaling in cancer
- Polyamine Metabolism and Applications
Papers in
-
- Metabolism, Diabetes, and Cancer 17
- PI3K/AKT/mTOR signaling in cancer 10
- Oncology 15
- Cancer-related Molecular Pathways 9
- Cancer Risks and Factors 5
- Co-authors
- Nahum Sonenberg (12 shared papers)Michaël Pollak (5 shared papers)Mahvash Zakikhani (4 shared papers)I. George Fantus (3 shared papers)Vuk Stambolic (15 shared papers)Pamela J. Goodwin (12 shared papers)Ivan Topisirović (4 shared papers)Bruno D. Fonseca (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)JNCI Cancer Spectrum (2 papers)Science (2 papers)Cancer Research (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- CanadaUnited StatesSwitzerland
In The Last Decade
Ryan J.O. Dowling
29 papers receiving 4.8k citations
Ryan J.O. Dowling's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 909
- Molecular Biology 3.8k
- Oncology 1.2k
- Aging 53
- Endocrinology, Diabetes and Metabolism 303
Countries citing papers authored by Ryan J.O. Dowling
This map shows the geographic impact of Ryan J.O. Dowling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan J.O. Dowling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan J.O. Dowling more than expected).
Fields of papers citing papers by Ryan J.O. Dowling
This network shows the impact of papers produced by Ryan J.O. Dowling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan J.O. Dowling. The network helps show where Ryan J.O. Dowling may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan J.O. Dowling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells Hit paper breakdown → | 2006 | 881 |
| 2 | Metformin Inhibits Mammalian Target of Rapamycin–Dependent Translation Initiation in Breast Cancer Cells Hit paper breakdown → | 2007 | 773 |
| 3 | mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs Hit paper breakdown → | 2010 | 551 |
| 4 | 2009 | 370 | |
| 5 | 2013 | 322 | |
| 6 | 2011 | 312 | |
| 7 | 2012 | 280 | |
| 8 | 2008 | 261 | |
| 9 | 2008 | 245 | |
| 10 | 2012 | 196 | |
| 11 | 2012 | 108 | |
| 12 | 2009 | 94 | |
| 13 | 2015 | 86 | |
| 14 | 2019 | 73 | |
| 15 | 2015 | 71 | |
| 16 | 2016 | 71 | |
| 17 | 2019 | 46 | |
| 18 | 2009 | 40 | |
| 19 | 2007 | 36 | |
| 20 | 2010 | 21 |
About Ryan J.O. Dowling
Ryan J.O. Dowling is a scholar working on Molecular Biology, Oncology, Surgery, Cancer Research and Epidemiology, having authored 30 papers that have together received 4.9k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (17 papers), PI3K/AKT/mTOR signaling in cancer (10 papers), Cancer-related Molecular Pathways (9 papers), Cancer Risks and Factors (5 papers), Pancreatic function and diabetes (4 papers), interferon and immune responses (3 papers), Cancer, Lipids, and Metabolism (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (909 citations), Molecular Biology (3.8k citations), Oncology (1.2k citations), Aging (53 citations) and Endocrinology, Diabetes and Metabolism (303 citations). Ryan J.O. Dowling has collaborated with scholars based in Canada, United States and Switzerland. Frequent co-authors include Nahum Sonenberg, Michaël Pollak, Mahvash Zakikhani, I. George Fantus, Vuk Stambolic, Pamela J. Goodwin, Ivan Topisirović, Bruno D. Fonseca, Saroj Niraula and Ola Larsson. Their work appears in journals such as Journal of Clinical Oncology, JNCI Cancer Spectrum, Science, Cancer Research and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.